EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Parkway Life Real Estate Investment Trust (C2PU) fair value: what the stock is really worth

As of Oct 1, 2026: fair value of Parkway Life Real Estate Investment Trust S$1.99, price S$4.02, upside -50.5%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Real Estate · SG · ISIN SG1V52937132

PL Broad data Sep 27, 2026

Parkway Life Real Estate Investment Trust

C2PU · SG

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value 1.99 SGD · Strongly overvalued (−50.5%)
!Quality 54/100
!Expensive Growth (revenue 5y +5.2 %/yr)
✓Highly profitable · 106.5% net margin (TTM) · excl. one-off gain FY2025 74.3%
✓Low debt · generates free cash flow
!4.1% dividend yield · Watch coverage
!Mixed vs. peers (8/15)
!Moderate moat 62/100
Watch Parkway Life Real Estate Investment Trust for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

4.35 SGD 2.96 SGD Fair Value 1.99 SGD Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.

How to read this chart

60‑month range 2.96 SGD – 4.35 SGD · fair‑value band 1.17 SGD – 2.81 SGD · the 4.02 SGD price screens above the 1.99 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.

Follow Parkway Life Real Estate Investment Trust in your weekly email

Every Wednesday you see whether Parkway Life Real Estate Investment Trust is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Parkway Life Real Estate Investment Trust is a unit trust constituted pursuant to the trust deed (as amended) (the Trust Deed) between Parkway Trust Management Limited (the Manager) and HSBC Institutional Trust Services (Singapore) Limited (the Trustee).

Show more

Parkway Life Real Estate Investment Trust is a unit trust constituted pursuant to the trust deed (as amended) (the Trust Deed) between Parkway Trust Management Limited (the Manager) and HSBC Institutional Trust Services (Singapore) Limited (the Trustee). On 12 July 2007, the Trust was declared as an authorized unit trust scheme under the Trustees Act, Chapter 337. The Trustee is under a duty to take into custody and hold the assets of the Trust and its subsidiaries (the Group) in trust for the holders (Unitholders) of units in the Trust. On 23 August 2007, the Trust was admitted to the Official List of the Singapore Exchange Securities Trading Limited and was included under the Central Provident Fund Investment Scheme on the same date. The principal activity of the Trust is to invest primarily in income-producing real estate and/or real estate-related assets in the Asia-Pacific region (including Singapore) that are used primarily for healthcare and/or healthcare-related purposes (including but not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices), whether wholly or partially owned, and whether directly or indirectly held through the ownership of special purpose vehicles whose primary purpose is to own such real estate. Parkway Life Real Estate Investment Trust is domiciled in Singapore and was established on July 07, 2007.

Stock analysis

Parkway Life Real Estate Investment Trust (C2PU) currently trades at 4.02 SGD, while our model-based Fair Value estimate is 1.99 SGD, 50.5% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Economic Profit group reads highest at a median of 2.37 SGD per share, and 0 of the 16 models we run sit above the 4.02 SGD price.

Bear case: the DCF Models group reads lowest at 0.5400 SGD, and 16 of the 16 models stay below the price. Evidence for this calculation is high.

Scenario range: 1.17 SGD (bear) to 2.81 SGD (bull), the price of 4.02 SGD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Real Estate sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Parkway Life Real Estate Investment Trust reported revenue of 156M SGD in FY2025 versus 121M SGD in FY2021, a compound +6.6%/yr. Reported net income was 153M SGD in FY2025, compounding −17.6%/yr from FY2021.

Key figures

Market cap 2.6B SGD (≈ $2.0B) · P/E ratio 16.1 · P/S ratio 15.8 · EPS (TTM) 0.2500 SGD · Dividend yield 4.1% · Net margin 98.0% · Return on equity 10.1% · Return on assets (EBIT) 4.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 49 out of 100 (medium confidence).

What moves the price

The share trades about 4% below its 52-week high and 6% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Real Estate peers we cover trades at 6% fair-value upside, at −51%, C2PU screens richer than that median.

Fair Value models

Bear 1.17 SGD Fair Value 1.99 SGD Bull 2.81 SGD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0647 SGD per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF n/a 0.0800 SGD >0.3200 SGD 77
Residual Income 2.18 SGD 2.37 SGD 2.77 SGD 76
Growth DCF n/a 0.0600 SGD >0.2400 SGD 75
All 16 models by family
DCF Models
FCF DCF n/a 0.0800 SGD >0.3200 SGD 77
5Y Revenue Exit n/a 0.5400 SGD 1.27 SGD 69
5Y EBITDA Exit 0.6100 SGD 1.73 SGD 3.01 SGD 71
10Y Revenue Exit n/a 0.3300 SGD 0.9700 SGD 64
10Y EBITDA Exit 0.2700 SGD 1.13 SGD 2.23 SGD 63
Dividend Discount
Gordon GGM 0.8800 SGD 1.68 SGD 2.66 SGD 66
DDM Multi-Stage 0.8800 SGD 1.33 SGD 1.79 SGD 66
Multiples
P/S Multiple 1.16 SGD 1.55 SGD 1.94 SGD 58
P/B Multiple 2.98 SGD 3.98 SGD 4.97 SGD 55
EV/EBIT 2.15 SGD 3.21 SGD 4.27 SGD 65
EV/EBITDA 1.43 SGD 2.25 SGD 3.06 SGD 66
EV/Revenue 0.1500 SGD 0.6500 SGD 1.15 SGD 48
Asset-Based
NCAV (Graham) 1.28 SGD 1.71 SGD 2.56 SGD 54
Growth DCF
Growth DCF n/a 0.0600 SGD >0.2400 SGD 75
Rev-Margin DCF n/a 0.5400 SGD 1.18 SGD 69
Economic Profit
Residual Income 2.18 SGD 2.37 SGD 2.77 SGD 76

Open the full fair value analysis →

Notify me when C2PU reaches fair value

Put C2PU on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 54/100

Of which business quality 52 · Market factors (momentum, volatility) 61

Profitability 39
Margins and returns on capital today
Quality Growth 43
Are margins and returns improving?
Cashflow 52
Earnings quality: real cash, not paper profit
Fin. Strength 60
Balance sheet, leverage, solvency risk
Investment 50
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 44
Price trend over the last 3–12 months (market factor)
52W Momentum 46
Distance to the 52-week high (market factor)
Net Issuance 69
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 53/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+7.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.2%
Start year 2020 (pandemic). Over 10 years: +4.3% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.3%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
≈ +8.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.1%
Dividend (yield on the price)4.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.2.8% vs 4.4%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.79% → 81%
Start year 2020 (pandemic)
⚠ Rate on operating basis: 2025 sits 61% above its own trend.

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+35.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+2.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (Singapore: IMF forecast 2.0% a year to 2030, 1.7% from 2016 to 2025) that is about +32.5% a year for the price and +0.7% for the forecasts.
Forecast 2026 (sales)+6.9%
Forecast 2027 (sales)+1.7%
Projected 2028 (sales)+1.8%
Projected 2029 (sales)+1.8%
Projected 2030 (sales)+1.8%

C2PU screens overvalued: fair value 51% below the price. Compare with Welltower Inc →

Compare Parkway Life Real Estate Investment Trust with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.REIT - Healthcare Facilities · 25 stocks

Beats the industry median on 8/15 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 54 · Above median
Fair Value upside −50.5% · Bottom 25%
Profitability
Return on equity (TTM) 10.1% · Above median
Return on assets 3.0% · Above median
Net margin (TTM) 106.5% · Top 25%
Operating margin (TTM) 80.9% · Top 25%
Growth and dividend
Revenue growth −1.0% · Bottom 25%
Dividend yield (TTM) 4.1% · Below median
Balance sheet
Debt / equity 0.43× · Below median

Valuation Multiplesvs REIT - Healthcare Facilities median · lower = cheaper

P/E (TTM) 16.1× · Cheaper than median
P/B 1.57× · Pricier than median
P/S (TTM) 16.92× · Priciest 25%
P/FCF 72.6× · Priciest 25%
EV/EBITDA 60.6× · Priciest 25%
PEG 4.75× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 38
FUTURE (revenue growth)0 · sector 56
PAST (return on equity)40 · sector 22
HEALTH (low debt)79 · sector 74
DIVIDEND (yield)82 · sector 100

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Welltower Inc WELL $230.24 $74.85 −67%
Ventas, Inc VTR $86.59 $34.57 −60%
Omega Healthcare Investors, Inc OHI $46.68 $57.16 +22%
Healthpeak Properties, Inc DOC $20.31 $16.01 −21%
American Healthcare REIT, Inc AHR $52.02 $15.32 −71%
CareTrust REIT, Inc CTRE $37.42 $39.79 +6%
Healthcare Realty Trust Incorporated HR $18.05 $20.82 +15%
Aedifica NV AED €64.50 €59.72 −7%
Sabra Health Care REIT, Inc SBRA $19.85 $22.26 +12%
National Health Investors, Inc NHI $66.66 $70.75 +6%

Explore undervalued stocks

More undervalued Real Estate stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Parkway Life Real Estate Investment Trust Fair Value". https://www.fairvalue-calculator.com/stock/C2PU

Frequently asked questions

Is Parkway Life Real Estate Investment Trust (C2PU) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of 1.99 SGD versus a price of 4.02 SGD, about −51% upside (overvalued).
What is the fair value of C2PU?
Our model-based fair value for Parkway Life Real Estate Investment Trust is 1.99 SGD (as of Sep 27, 2026), built from audited fundamentals. The current price: 4.02 SGD.
What is the quality score of C2PU?
Parkway Life Real Estate Investment Trust has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Parkway Life Real Estate Investment Trust (C2PU)?
Our model-based price target is the fair value of 1.99 SGD (as of Sep 27, 2026) from 16 valuation models. Cautious scenario 1.17 SGD, optimistic scenario 2.81 SGD. It is a calculation from audited fundamentals, not an analyst target.
What is the Parkway Life Real Estate Investment Trust stock forecast for 2026?
Our models put fair value at 1.99 SGD, about −51% upside versus a price of 4.02 SGD (overvalued). Cautious scenario 1.17 SGD, optimistic scenario 2.81 SGD. The calculation is refreshed regularly with new filings.
What is the revenue of Parkway Life Real Estate Investment Trust (C2PU)?
Parkway Life Real Estate Investment Trust reported trailing-twelve-month revenue of about 155M SGD (latest available figure, as of Sep 27, 2026).
Does Parkway Life Real Estate Investment Trust pay a dividend?
Parkway Life Real Estate Investment Trust currently shows a dividend yield of about 4.08% relative to its recent price (as of Sep 27, 2026).
What growth is priced into Parkway Life Real Estate Investment Trust (C2PU)?
For today's price to be fair in a discounted-cash-flow model, Parkway Life Real Estate Investment Trust would have to grow free cash flow by +35.2 % per year for five years (discount rate 8.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.2 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of C2PU use?
Our models discount Parkway Life Real Estate Investment Trust at 8.3 %: a base by market capitalisation (mid), damped by beta 0.34, country premium for Singapore. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Parkway Life Real Estate Investment Trust that is +35.2 % per year a year over ten years, using the same discount rate (8.3 %) and the same formula as our fair value.
How much growth has Parkway Life Real Estate Investment Trust (C2PU) delivered so far?
Over the past 5 years revenue at Parkway Life Real Estate Investment Trust grew +5.2 % a year. The price currently implies +35.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Parkway Life Real Estate Investment Trust (C2PU) growing?
The median revenue growth in the sector is +2.2 % a year. That is the yardstick for the growth priced into Parkway Life Real Estate Investment Trust (+35.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Parkway Life Real Estate Investment Trust (C2PU)?
The free-cash-flow yield on the price is 1.38 %: that much free cash flow Parkway Life Real Estate Investment Trust produces per unit of market value. When it exceeds the discount rate of our models (8.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Parkway Life Real Estate Investment Trust (C2PU)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Parkway Life Real Estate Investment Trust it is 1.99 SGD per share (as of Sep 27, 2026), against a price of 4.02 SGD. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Parkway Life Real Estate Investment Trust stock overvalued or undervalued in 2026?
As of Sep 27, 2026, C2PU trades above its calculated fair value: price 4.02 SGD, fair value 1.99 SGD, a gap of about −51% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of C2PU?
No. The price is what the market pays today (4.02 SGD); the fair value is what the company's own numbers justify (1.99 SGD). For Parkway Life Real Estate Investment Trust the two are 2.03 SGD per share apart. That gap is exactly why we show both numbers side by side.
How much is Parkway Life Real Estate Investment Trust worth?
The market values Parkway Life Real Estate Investment Trust at about 2.6B SGD (market capitalisation, as of Sep 27, 2026). Per share that is 4.02 SGD; our models calculate a fair value of 1.99 SGD per share.
What do the bullish and bearish scenarios say about C2PU?
Our models span a range for Parkway Life Real Estate Investment Trust: cautious scenario 1.17 SGD, base 1.99 SGD, optimistic 2.81 SGD per share (as of Sep 27, 2026, price 4.02 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of C2PU?
Parkway Life Real Estate Investment Trust trades at a price-to-earnings ratio of 16.1 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1.99 SGD is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 22.6 (reported for FY2025: 17.2). Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, FY2025 ex one-offs: 20.0. Other multiples: PEG 4.8, P/B 1.6, P/S 16.9, EV/EBITDA 60.6.
What is the PEG ratio of C2PU?
The PEG ratio of Parkway Life Real Estate Investment Trust is 4.75 (P/E divided by earnings growth, as of Sep 27, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Parkway Life Real Estate Investment Trust (C2PU)?
Balance-sheet figures for Parkway Life Real Estate Investment Trust (as of Sep 27, 2026): return on equity 10.1%, debt of 0.43 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is C2PU from its 52-week high?
Parkway Life Real Estate Investment Trust trades at 4.02 SGD, about 4% below its 52-week high of 4.18 SGD and 6% above the low of 3.81 SGD (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of 1.99 SGD is for.
Which stocks are comparable to Parkway Life Real Estate Investment Trust?
From the same area (Real Estate) we also value Welltower Inc, Ventas, Inc, Omega Healthcare Investors, Inc, Healthpeak Properties, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Parkway Life Real Estate Investment Trust stock attractive at the current price?
The data as of Sep 27, 2026: price 4.02 SGD, calculated fair value 1.99 SGD (−51%), Quality Score 54/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of C2PU calculated?
We run Parkway Life Real Estate Investment Trust through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1.99 SGD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Parkway Life Real Estate Investment Trust itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Parkway Life Real Estate Investment Trust (C2PU)?
The closing price on Oct 1, 2026 was 4.02 SGD. Our model-based fair value is 1.99 SGD, about −51% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Parkway Life Real Estate Investment Trust right now?
The price sits above even our optimistic bull case (2.81 SGD). The favourable scenario is already priced in. Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (1.17 SGD to 2.81 SGD) leaves room in how you read the outcome. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.

Key figures of Parkway Life Real Estate Investment Trust

How large is the market capitalisation of Parkway Life Real Estate Investment Trust (C2PU)?
The market capitalisation of Parkway Life Real Estate Investment Trust is 2.6B SGD (≈ $2.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Parkway Life Real Estate Investment Trust (C2PU)?
The price-to-sales ratio of Parkway Life Real Estate Investment Trust is 15.8 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Parkway Life Real Estate Investment Trust (C2PU)?
Earnings per share at Parkway Life Real Estate Investment Trust are 0.2500 SGD (price ÷ EPS = P/E 16.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Parkway Life Real Estate Investment Trust (C2PU)?
The dividend yield of Parkway Life Real Estate Investment Trust is 4.1% (payout 86.6%, on adjusted earnings, reported 65.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Parkway Life Real Estate Investment Trust (C2PU)?
The net margin of Parkway Life Real Estate Investment Trust is 98.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Parkway Life Real Estate Investment Trust (C2PU)?
The return on equity (ROE) of Parkway Life Real Estate Investment Trust is 10.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Parkway Life Real Estate Investment Trust (C2PU)?
On an EBIT basis the return on assets of Parkway Life Real Estate Investment Trust is 4.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Parkway Life Real Estate Investment Trust (C2PU)?
The operating margin of Parkway Life Real Estate Investment Trust is 80.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Parkway Life Real Estate Investment Trust (C2PU)?
Revenue at Parkway Life Real Estate Investment Trust is growing −1.0% versus a year earlier (3y avg +6.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Parkway Life Real Estate Investment Trust (C2PU)?
Earnings per share at Parkway Life Real Estate Investment Trust are growing +21.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Parkway Life Real Estate Investment Trust (C2PU) carry?
The net debt of Parkway Life Real Estate Investment Trust is 836M SGD (fiscal year 2025, ≈ 23.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Parkway Life Real Estate Investment Trust in the live analysis

One click puts Parkway Life Real Estate Investment Trust on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.